MicroRNA-139-5p improves sepsis-induced lung injury by targeting Rho-kinase1.
Rho-kinase 1
acute lung injury
apoptosis
inflammation
microRNA
sepsis
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
05
11
2020
accepted:
24
03
2021
entrez:
26
8
2021
pubmed:
27
8
2021
medline:
27
8
2021
Statut:
ppublish
Résumé
Sepsis-induced acute lung injury (ALI) is an inflammatory process that involves inflammatory cytokine production and cell apoptosis. In the present study, the regulatory role of microRNA (miR)-139-5p in sepsis-induced ALI was investigated using a murine model of cecal ligation puncture (CLP) and an
Identifiants
pubmed: 34434273
doi: 10.3892/etm.2021.10493
pii: ETM-0-0-10493
pmc: PMC8353635
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1059Informations de copyright
Copyright: © Zhao et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Theranostics. 2020 Jul 9;10(19):8771-8789
pubmed: 32754277
Am J Respir Crit Care Med. 2018 Mar 15;197(6):747-756
pubmed: 29232157
Oncol Lett. 2018 Jul;16(1):829-834
pubmed: 29963151
Cancer Discov. 2016 Jun;6(6):601-11
pubmed: 27102076
Theranostics. 2020 Jun 5;10(16):7335-7350
pubmed: 32641995
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674720
Antioxid Redox Signal. 2007 Nov;9(11):1991-2002
pubmed: 17760509
Onco Targets Ther. 2020 Mar 17;13:2319-2331
pubmed: 32256083
Am J Physiol Lung Cell Mol Physiol. 2019 Apr 1;316(4):L656-L668
pubmed: 30702344
Ann N Y Acad Sci. 2019 Feb;1437(1):43-56
pubmed: 30499145
Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
pubmed: 21531958
Onco Targets Ther. 2020 Feb 12;13:1277-1287
pubmed: 32103995
Circulation. 2007 Aug 14;116(7):793-802
pubmed: 17698745
Front Oncol. 2019 Oct 22;9:1103
pubmed: 31696057
Biomed Pharmacother. 2019 Aug;116:109012
pubmed: 31146107
Ann Surg. 2021 Mar 1;273(3):523-531
pubmed: 31058700
Mol Med Rep. 2018 Nov;18(5):4486-4498
pubmed: 30221694
BMJ. 2016 May 23;353:i1585
pubmed: 27217054
Lancet. 2018 Jul 7;392(10141):75-87
pubmed: 29937192
Lancet Oncol. 2017 Jan;18(1):75-87
pubmed: 27908594
Exp Ther Med. 2019 Nov;18(5):4049-4057
pubmed: 31616518
Cancer Res. 2018 Jan 15;78(2):501-515
pubmed: 29180477
FEBS J. 2016 Apr;283(8):1438-52
pubmed: 26859226
Neurobiol Dis. 2014 Mar;63:184-93
pubmed: 24333693
J Clin Invest. 2019 Jan 2;129(1):296-309
pubmed: 30507610
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
JAMA. 2019 Oct 1;322(13):1261-1270
pubmed: 31573637
Am J Cancer Res. 2019 Jun 01;9(6):1212-1223
pubmed: 31285953
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Trends Microbiol. 2011 Apr;19(4):198-208
pubmed: 21296575
Nature. 2018 Jul;559(7712):114-119
pubmed: 29950719
Intensive Care Med Exp. 2016 Dec;4(1):22
pubmed: 27430881
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1254-1264.e1
pubmed: 29221736
J Cell Mol Med. 2020 Jan;24(1):1022-1035
pubmed: 31756053
Nat Rev Drug Discov. 2010 Apr;9(4):293-307
pubmed: 20380038
Pathol Oncol Res. 2020 Jan;26(1):133-139
pubmed: 29270775